e-learning
resources
London 2016
Monday, 05.09.2016
IPF: from pathogenesis to treatment II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A supportive care decision aid tool for idiopathic pulmonary fibrosis
Charles Sharp (Bristol, United Kingdom), Charles Sharp, Adrienne Edwards, Heather Lamb, Sorayya Alam, Nikki Jordan, Rachel Gunary, Patricia Meek, Ann Millar, Clare Kendall, Huzaifa Adamali
Source:
International Congress 2016 – IPF: from pathogenesis to treatment II
Session:
IPF: from pathogenesis to treatment II
Session type:
Poster Discussion
Number:
2102
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Charles Sharp (Bristol, United Kingdom), Charles Sharp, Adrienne Edwards, Heather Lamb, Sorayya Alam, Nikki Jordan, Rachel Gunary, Patricia Meek, Ann Millar, Clare Kendall, Huzaifa Adamali. A supportive care decision aid tool for idiopathic pulmonary fibrosis. Eur Respir J 2016; 48: Suppl. 60, 2102
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
End-of-life care in in-patients dying from pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Do physicians in primary health care recognize pulmonary fibrosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Integrating early palliative care for patients with idiopathic pulmonary fibrosis and their caregivers
Source: Virtual Congress 2020 – Fear and anxiety, psychological wellbeing and prevention of psychological distress in chronic lung diseases
Year: 2020
IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
Review of care in patients dying of pulmonary fibrosis in a district general hospital
Source: International Congress 2016 – Orphan diseases I
Year: 2016
The physical and psychological needs of patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
An educational initiative to improve the team-based care of patients with idiopathic pulmonary fibrosis
Source: ERJ Open Res, 4 (1) 00093-2017; 10.1183/23120541.00093-2017
Year: 2018
The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
Palliative and end-of-life care for patients with respiratory disease
Source: Eur Respir Mon; 2009: 43:327–353
Year: 2009
Palliative care and end of life decisions in chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine
Year: 2010
Development of a national patient charter for idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF clinical
Year: 2016
Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Palliative and end-of-life care for patients with severe COPD
Source: Eur Respir J 2008; 32: 796-803
Year: 2008
End-of-life care communication in chronic obstructive pulmonary disease: A survey applied to Portuguese respirologists
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013
Palliative care in COPD patients: is it only an end-of-life issue?
Source: Eur Respir Rev 2012 21: 347-354
Year: 2012
Palliative care for patients with pulmonary fibrosis: symptom relief is essential
Source: Eur Respir J, 52 (6) 1802086; 10.1183/13993003.02086-2018
Year: 2018
Benefits of pulmonary rehabilitation and predictor of changes in exercise capacity for idiopathic pulmonary fibrosis
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014
Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2014; 23: 3-4
Year: 2014
Supportive therapy
Source: Annual Congress 2007 - Primary care: palliative care challenges. Behavioural and emotional aspects
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept